A Clínic-IDIBAPS study discovers that nanoparticles with DNA enhance the effect of immunotherapy against cancer
A study co-led by Sònia Guedan, head of the IDIBAPS Cellular immunotherapies for cancer group, has shown in various animal cancer models that the...
